Dr. Cheryl L.Willman

Dr. Cheryl L. Willman, MD, is an internationally recognized physician-scientist and cancer genomics expert with a focus on acute leukemias and health equity in oncology. She currently serves as the Executive Director of Mayo Clinic Cancer Programs and Director of the Mayo Clinic Comprehensive Cancer Center, where she leads efforts across Mayo’s multi-state cancer enterprise. Prior to joining Mayo Clinic, Dr. Willman served for over two decades as the founding Director and CEO of the University of New Mexico Comprehensive Cancer Center. She received her medical degree from Mayo Clinic Alix School of Medicine and completed postgraduate training in pathology and cancer research at the University of New Mexico and the University of Washington. She is board-certified in Anatomic and Clinical Pathology and is widely regarded for her leadership in advancing precision medicine and cancer care delivery for underserved populations.